You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 6,309,663


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,309,663
Title: Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
Abstract:The present invention relates to pharmaceutical compositions, pharmaceutical systems, and methods for enhanced absorption of hydrophilic therapeutic agents. Compositions and systems of the present invention include an absorption enhancing carrier, where the carrier is formed from a combination of at least two surfactants, at least one of which is hydrophilic. A hydrophilic therapeutic agent can be incorporated into the composition, or can be co-administered with the composition as part of a pharmaceutical system. The invention also provides methods of treatment with hydrophilic therapeutic agents using these compositions and systems.
Inventor(s): Patel; Mahesh V. (Salt Lake City, UT), Chen; Feng-Jing (Salt Lake City, UT)
Assignee: Lipocine Inc. (Salt Lake City, UT)
Application Number:09/375,636
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,309,663
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

United States Patent 6,309,663: A Comprehensive Analysis

Introduction

United States Patent 6,309,663, titled "Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents," presents a significant innovation in pharmaceutical formulations. This patent, issued to enhance the bioabsorption of hydrophilic therapeutic agents, is a crucial development in the field of pharmacology. Here, we will delve into the claims, the patent landscape, and the strategic insights derived from this patent.

Patent Overview

Invention Description

The patent describes triglyceride-free pharmaceutical compositions and methods designed to improve the absorption of hydrophilic therapeutic agents. These compositions include an absorption-enhancing carrier with at least two surfactants, one of which is hydrophilic, and a hydrophilic therapeutic agent. The surfactants are formulated to create an aqueous dispersion with a very small average particle size upon mixing with an aqueous diluent, thereby enhancing the bioabsorption of the therapeutic agent[4].

Claims Analysis

Key Claims

  • The patent claims cover a dosage form of an absorption-enhancing composition that includes at least two surfactants and a hydrophilic therapeutic agent.
  • The surfactants must be present in amounts that form an aqueous dispersion with a very small average particle size when mixed with an aqueous diluent.
  • The hydrophilic therapeutic agent can be solubilized, suspended, or partially solubilized and suspended in the absorption-enhancing carrier[4].

Novelty and Nonobviousness

To be patentable, the claimed invention must meet the requirements of novelty and nonobviousness. The novelty requirement ensures that the claimed invention is new and not previously disclosed in the prior art. The nonobviousness requirement ensures that the invention is not an obvious variation of existing technology. The unique combination of triglyceride-free surfactants and the specific formulation to enhance bioabsorption likely satisfies these requirements[2].

Patent Landscape Analysis

Geographical Spread

Understanding the geographical spread of patents in this technology area is crucial. The patent landscape analysis would reveal where similar patents are being filed and granted, helping to identify key markets and potential competitors. For instance, if there is a high concentration of similar patents in the U.S. and Europe, it may indicate a more saturated market in these regions[3].

Saturation Level

The saturation level of the patent space for triglyceride-free pharmaceutical compositions needs to be assessed. A highly saturated space might indicate that it is challenging to secure new claims in this area, suggesting the need to explore alternative technologies or niche areas within the broader field[3].

Competitive Landscape

Identifying new entrants and tracking changes over time (time-slicing) is essential. This analysis helps in understanding the competitive patenting strategies and how they evolve. For example, if a competitor has recently shifted focus from traditional triglyceride-based formulations to triglyceride-free compositions, it could signal a market trend and an opportunity for innovation[3].

Strategic Insights

Decision-Making for R&D and Business

A comprehensive patent landscape analysis provides critical data for R&D and business decision-makers. It helps in determining whether to invest in a particular technology area, how to navigate a saturated patent space, and where to focus resources for maximum impact. For instance, if the analysis reveals underappreciated niche areas within the triglyceride-free compositions, it could guide the company to pivot towards these areas for future research and development[3].

Time-Slicing and Competitive Analysis

Time-slicing involves analyzing patent data over time to understand changes in competitive patenting strategies. This can reveal shifts in technology focus, geographical coverage, or patent renewal strategies. For example, if a competitor has significantly reduced patent filings in a particular area, it might indicate an abandonment of that technology, creating an opportunity for other companies to fill the gap[3].

Challenges and Opportunities

PTAB and IPR Considerations

The Patent Trial and Appeal Board (PTAB) and Inter Partes Review (IPR) processes are crucial in challenging the validity of patents. If a patent like US 6,309,663 is challenged, it must withstand the scrutiny of PTAB, which includes determining whether the patent claims are directed to ineligible subject matter and whether they have an inventive concept. Understanding these processes can help in strategizing patent defense and litigation[2].

Market Impact

The market impact of this patent can be significant, especially in the pharmaceutical industry where bioabsorption is a critical factor. Companies can leverage this technology to develop more effective drugs, which could lead to market dominance. However, navigating the competitive landscape and ensuring that the patent remains valid are essential for maintaining this advantage.

Expert Insights

According to industry experts, "A comprehensive patent landscape analysis is not just about identifying existing patents but also about uncovering strategic insights that can guide long-term business decisions." This is particularly relevant in the pharmaceutical sector, where innovation is rapid and competitive[3].

Statistics and Examples

  • The U.S. patent litigation landscape has seen a 20% increase in the third quarter of 2024 compared to the same period in 2023, highlighting the increasing importance of robust patent strategies[5].
  • A company focusing a significant portion of its resources on a niche technology, such as triglyceride-free compositions, can achieve a competitive edge. For example, if a company has 25 patents in this niche area, which constitutes 33% of its entire patent portfolio, it indicates a strong commitment to this technology[3].

Key Takeaways

  • Innovation in Formulations: The patent highlights the importance of innovative formulations in enhancing the bioabsorption of hydrophilic therapeutic agents.
  • Patent Landscape Analysis: Conducting a thorough patent landscape analysis is crucial for strategic decision-making in R&D and business.
  • Competitive Strategy: Understanding the competitive landscape, including geographical spread and saturation levels, is vital for navigating the patent space effectively.
  • Regulatory Considerations: The validity of patents can be challenged through PTAB and IPR, making it essential to ensure that patents meet the requirements of novelty, nonobviousness, and inventive concept.

Frequently Asked Questions (FAQs)

What is the main innovation of US Patent 6,309,663?

The main innovation is the development of triglyceride-free pharmaceutical compositions that enhance the bioabsorption of hydrophilic therapeutic agents through a specific formulation of surfactants.

How does the patent landscape analysis help in this context?

Patent landscape analysis helps in understanding the geographical spread, saturation level, and competitive strategies in the field of triglyceride-free pharmaceutical compositions, guiding R&D and business decisions.

What are the key challenges in maintaining the validity of this patent?

The key challenges include withstanding PTAB and IPR challenges, ensuring the patent claims are not directed to ineligible subject matter, and demonstrating an inventive concept.

How can companies leverage this technology for market dominance?

Companies can leverage this technology by developing more effective drugs with enhanced bioabsorption, navigating the competitive landscape effectively, and ensuring robust patent strategies.

What is the significance of time-slicing in patent landscape analysis?

Time-slicing helps in tracking changes in competitive patenting strategies over time, revealing shifts in technology focus, geographical coverage, or patent renewal strategies, which can guide long-term business decisions.

Cited Sources:

  1. Canadian Patents Database - FORMULATION COMPRISING A DRUG OF LOW WATER SOLUBILITY AND METHOD OF USE THEREOF.
  2. Congressional Research Service - The Patent Trial and Appeal Board and Inter Partes Review.
  3. AcclaimIP - Patent Landscape Analysis - Uncovering Strategic Insights.
  4. Google Patents - US6309663B1 - Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents.
  5. RPX Corporation - Q3 in Review: US NPE Upswing Continues as UPC Comes Further into Focus.

More… ↓

⤷  Subscribe

Details for Patent 6,309,663

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Emd Serono, Inc. PERGONAL menotropins For Injection 017646 August 22, 1975 6,309,663 2039-02-26
Emd Serono, Inc. PERGONAL menotropins For Injection 017646 May 20, 1985 6,309,663 2039-02-26
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 October 28, 1982 6,309,663 2039-02-26
Eli Lilly And Company HUMULIN R U-500 insulin human Injection 018780 December 29, 2015 6,309,663 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.